Catalent
CTLT
#1601
Rank
โ‚น909.86 B
Marketcap
โ‚น5,013
Share price
-0.85%
Change (1 day)
76.70%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : โ‚น518.82 Billion

According to Catalent's latest financial reports the company's total liabilities are โ‚น518.82 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Catalent - Total liabilities on balance sheet (from 2013 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-06-30โ‚น506.07 B11.88%
2022-06-30โ‚น452.32 B25.85%
2021-06-30โ‚น359.40 B11.16%
2020-06-30โ‚น323.31 B20.36%
2019-06-30โ‚น268.61 B13.94%
2018-06-30โ‚น235.75 B33.26%
2017-06-30โ‚น176.91 B6.88%
2016-06-30โ‚น165.51 B3.72%
2015-06-30โ‚น159.58 B-23.22%
2014-06-30โ‚น207.85 B3.92%
2013-06-30โ‚น200.02 B3.25%
2012-06-30โ‚น193.71 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚น30.23 B-94.17%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น45.52 B-91.23%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น641.18 B 23.59%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
โ‚น27.11 B-94.77%๐Ÿ‡บ๐Ÿ‡ธ USA